Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Acute Leukemias II

Prognostic Factors and Treatment Strategies
Buch | Softcover
XXI, 776 Seiten
1990
Springer Berlin (Verlag)
978-3-540-50984-4 (ISBN)

Lese- und Medienproben

Acute Leukemias II -
CHF 149,75 inkl. MwSt
Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero unsatisfactory cure rates even in special sub geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa effective supportive care show some increase tients other cases prove to be highly resis in the initial response rates and certain im tant. The curability is superior in acute provements in the long-term results, no ben lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.

Leukemia Cell Biology and Basic Science.- Acute Myelogenous Leukemia in Children.- Acute Myelogenous Leukemia in Adults.- Acute Lymphoblastic Leukemia in Adults.- Acute Lymphoblastic Leukemia in Children.- Supportive Care in Acute Leukemias.- Treatment of Relapse and Pharmacokinetics.- Bone Marrow Transplantation.- Hematopoietic Growth Factors.

Erscheint lt. Verlag 19.1.1990
Reihe/Serie Haematology and Blood Transfusion Hämatologie und Bluttransfusion
Zusatzinfo XXI, 776 p. 45 illus.
Verlagsort Berlin
Sprache englisch
Maße 170 x 242 mm
Gewicht 1372 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Pädiatrie
Schlagworte adoptive Immuntherapie • Akute Leukämie • classification • Hämatopoetische Wachstumsfaktoren • Imaging • Knochenmarktransplantation • Leukämie • Morbidity
ISBN-10 3-540-50984-4 / 3540509844
ISBN-13 978-3-540-50984-4 / 9783540509844
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95